IP Library › Granted Patent US 7,569,612
Granted Patent B1
US 7,569,612 · App. 12/141,377 · Granted Aug 4, 2009

Methods of use of fenofibric acid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,569,612
App. No.
12/141,377
Granted
Aug 4, 2009
Kind
B1
Abstract

Fenofibric acid formulations comprising 105 mg of fenofibric acid are described as well as methods of use thereof. Dosage forms include, for example, immediate-release dosage forms.

Claims (2)

1. A method of treating a patient in need of treatment for primary hypercholesterolemia or mixed hyperlipidemia, comprising

administering to the patient an immediate-release 105 mg fenofibric acid dosage form without regard to meals, wherein immediate-release is release of 90% or greater of the fenofibric acid in the dosage form at 2 hours measured in a single pH buffer.

Assignments (15)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2025
From: ATHENA BIOSCIENCE, LLC
To: ROSEMONT PHARMACEUTICALS LLC
Reel/Frame 073287/0566 →
SECURITY INTEREST Recorded Oct 29, 2025
From: ATHENA BIOSCIENCE, LLC; ROSEMONT PHARMACEUTICALS LLC; PALMETTO PHARMACEUTICALS, LLC
To: GLAS TRUST CORPORATION LIMITED, AS SECURITY AGENT
Reel/Frame 072722/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2019
From: ARALEZ PHARMACEUTICALS TRADING DAC
To: ATHENA BIOSCIENCE, LLC
Reel/Frame 048930/0107 →
RELEASE OF SECURITY INTEREST Recorded Feb 20, 2019
From: DEERFIELD MANAGEMENT COMPANY L.P.
To: ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY
Reel/Frame 048386/0902 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY PREVIOUSLY RECORDED AT REEL: 046696 FRAME: 0772. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 30, 2018
From: ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 046988/0741 →
SECURITY INTEREST Recorded Aug 24, 2018
From: ARALEZ PHARMACEUTICAL TRADING DAC
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 046696/0772 →
NUNC PRO TUNC ASSIGNMENT Recorded Dec 21, 2016
From: TRIBUTE PHARMACEUTICALS INTERNATIONAL INC.
To: ARALEZ PHARMACEUTICALS TRADING DAC
Reel/Frame 041091/0860 →
CORRECTIVE ASSIGNMENT TO CORRECT THE JURISDICTION OF INCORPORATION PREVIOUSLY RECORDED ON REEL 035700 FRAME 0819. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 2, 2015
From: MUTUAL PHARMACEUTICAL COMPANY, INC.
To: TRIBUTE PHARMACEUTICALS INTERNATIONAL INC.
Reel/Frame 035831/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2015
From: MUTUAL PHARMACEUTICAL COMPANY, INC.
To: TRIBUTE PHARMACEUTICALS INTERNATIONAL INC.
Reel/Frame 035700/0819 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2012
From: MPC OLDCO, INC.
To: MUTUAL PHARMACEUTICAL COMPANY, INC.
Reel/Frame 029526/0361 →
MERGER Recorded Nov 30, 2012
From: AR HOLDING COMPANY, INC.
To: MPC OLDCO, INC.
Reel/Frame 029378/0850 →
RELEASE OF SECURITY INTEREST Recorded Aug 15, 2011
From: UBS AG, STAMFORD BRANCH, A SWISS BANKING INSTITUTION
To: MUTUAL PHARMACEUTICAL COMPANY, INC., A PENNSYLVANIA CORPORATION
Reel/Frame 026747/0703 →
RELEASE OF SECURITY INTEREST Recorded Aug 4, 2011
From: UBS AG, STAMFORD BRANCH, A SWISS BANKING INSTITUTION
To: MUTUAL PHARMACEUTICAL COMPANY, INC., A PENNSYLVANIA CORPORATION
Reel/Frame 026700/0240 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2009
From: MUTUAL PHARMACEUTICAL COMPANY, INC.
To: AR HOLDING COMPANY, INC.
Reel/Frame 023584/0012 →
PATENT SECURITY AGREEMENT Recorded Mar 18, 2009
From: MUTUAL PHARMACEUTICAL COMPANY, INC.
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 022414/0719 →